{
  "created_at": "Wed Dec 08 12:23:6 +0000 2021",
  "id_str": "1468549256420151305",
  "full_text": "Omicron was able to elude two doses of the Covid-19 vaccine from Pfizer and BioNTech in initial lab testing, but three doses neutralized the variant, the companies said https://t.co/efJcH1q2Lx",
  "display_text_range": [
    0,
    192
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/efJcH1q2Lx",
        "expanded_url": "https://on.wsj.com/3pwlzda",
        "display_url": "on.wsj.com/3pwlzda",
        "indices": [
          169,
          192
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 75,
  "favorite_count": 148,
  "possibly_sensitive": false,
  "original_created_at": "Wed Dec 08 11:53:21 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "オミクロンは、初期の実験では、ファイザー社とバイオンテック社のCovid-19ワクチンの2回の投与を逃れることができたが、3回の投与でこの変種を中和することができたと両社は発表した。https://t.co/efJcH1q2Lx"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司和BioNTech公司在最初的实验室测试中，Omicron能够躲过两剂Covid-19疫苗，但三剂疫苗能够中和该变体，这些公司说https://t.co/efJcH1q2Lx。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司和BioNTech公司在最初的實驗室測試中，Omicron能夠躲過兩劑Covid-19疫苗，但三劑疫苗能夠中和該變體，這些公司說https://t.co/efJcH1q2Lx。"
    }
  ]
}